Engrail Therapeutics
San Diego, US · Founded 2019 · 32 employees on LinkedIn · 11 known investors
Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders. Founded in 2019, it focuses on the neuroscience area to treat central nervous system conditions.
Founders & leadership
Engrail Therapeutics was founded in 2019 by Stephen.
S
StephenCo-founder, EVP Research & Development and Chief Development Officer
PC
Paul CayerinChief Financial Officer
V
VikramPresident and Chief Executive Officer
K
KimberlyChief Scientific Officer
Q
QuentinChief Technical Officer
Investors · 11
Foresite Capital✓ verifiedWest Hollywood
Longwood Fund✓ verifiedBoston
Norwest Venture Partners✓ verifiedMenlo Park · $10M – $30M
RiverVest Venture Partners✓ verifiedSt. Louis · $500K – $3M
Ysios Capital✓ verifiedBarcelona · $5.4M – $21.6M
abrdn plc✓ verifiedEdinburgh
Eight Roads Ventures✓ verifiedMumbai · $5M – $30M
Forbion✓ verifiedNaarden
Pivotal Life Sciences✓ verifiedSan Francisco
F-Prime CapitalCambridge · $3M – $10M
Red Tree VentureSan Diego
Funding
SEC filings, press & company announcements$314M disclosed across 2 rounds · 2024
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Engrail Therapeutics do?
- Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders. Founded in 2019, it focuses on the neuroscience area to treat central nervous system conditions.
- Who founded Engrail Therapeutics?
- Engrail Therapeutics was founded by Stephen in 2019.
- Who are Engrail Therapeutics's investors?
- Engrail Therapeutics's investors include Foresite Capital, Longwood Fund, Norwest Venture Partners, RiverVest Venture Partners, Ysios Capital, abrdn plc, Eight Roads Ventures, Forbion and 3 more.
- How much funding has Engrail Therapeutics raised?
- Engrail Therapeutics has disclosed $314M raised across 2 rounds.
- Where is Engrail Therapeutics headquartered?
- Engrail Therapeutics is headquartered in San Diego, US.